Emergent Biosolutions Inc (EBS) Key Ratios
$5.91
As on 28-Aug-2026 13:42EDT
Market cap
$247 Mln
Revenue (TTM)
$770 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 50.10 | 66.29 | -9.56 | -10.46 | -14.73 |
| EBIT | -- | -- | -64.62 | 31.47 | -33.23 |
| Net Profit | -2,750.00 | -1,401.67 | -226.74 | 19.72 | -190.01 |
| EPS | -3,001.65 | -1,477.33 | -243.02 | 19.73 | -191.40 |
| Book Value | -- | -- | 11.96 | -28.95 | -17.81 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -0.63 | 2.02 | 7.95 | 19.13 | -5.00 |
| Net Margin
| -- | -3.37 | -22.96 | -- | -- |
| Return on equity
| -32.63 | -19.53 | -40.93 | 10.46 | -33.67 |
| Return on Capital
| -14.93 | -8.75 | -- | 4.67 | -14.29 |
| Return on Assets
| -12.82 | -7.57 | -12.70 | 3.88 | -11.86 |
| Debt to Equity (x)
| -- | -- | 1.70 | 1.09 | 1.40 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
--
|
4.67
|
-14.29
|
-35.18
|
-7.99
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-40.93
Lower than Peers by 59.90
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
-40.93
|
10.46
|
-33.67
|
-74.67
|
-14.11
|
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
ROA
-12.70
Lower than Peers by 15.56
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
-12.70
|
3.88
|
-11.86
|
-30.48
|
-6.91
|
|
Peer Median
|
2.86
|
--
|
--
|
--
|
--
|
EBIT Margin
7.95
Lower than Peers by 7.87
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
7.95
|
19.13
|
-5.00
|
-16.02
|
-9.78
|
|
Peer Median
|
15.82
|
--
|
--
|
--
|
--
|
Net Margin
-22.96
Lower than Peers by 31.19
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
-22.96
|
7.08
|
-18.26
|
-72.48
|
-19.14
|
|
Peer Median
|
8.23
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-9.56
Lower than Peers by 17.61
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
-9.56
|
-0.29
|
-0.01
|
-0.06
|
-0.37
|
|
Peer Median
|
8.05
|
--
|
--
|
--
|
--
|
EBIT Growth
-64.62
Lower than Peers by 72.89
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
-64.62
|
372.22
|
68.95
|
-53.80
|
-128.32
|
|
Peer Median
|
8.26
|
--
|
--
|
--
|
--
|
Net Profit Growth
-226.74
Lower than Peers by 234.47
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
-226.74
|
127.60
|
74.94
|
-259.40
|
-196.40
|
|
Peer Median
|
7.73
|
--
|
--
|
--
|
--
|
EPS Growth
-243.02
Lower than Peers by 253.41
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
-243.02
|
1.29
|
0.76
|
-2.46
|
-2.03
|
|
Peer Median
|
10.39
|
--
|
--
|
--
|
--
|
Book Value Growth
-33.12
Lower than Peers by 38.00
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
-33.12
|
--
|
--
|
--
|
--
|
|
Peer Median
|
4.87
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
1.70
Higher than Peers by 1.11
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
1.70
|
1.09
|
1.40
|
1.32
|
1.03
|
|
Peer Median
|
0.59
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
--
|
--
|
0.01
|
0.64
|
0.69
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
5.42
Higher than Peers by 3.77
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
5.42
|
5.01
|
3.69
|
1.04
|
0.98
|
|
Peer Median
|
1.65
|
--
|
--
|
--
|
--
|
Quick Ratio
2.95
Higher than Peers by 1.75
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
2.95
|
2.41
|
1.77
|
0.54
|
0.70
|
|
Peer Median
|
1.20
|
--
|
--
|
--
|
--
|
Interest Coverage
-1.87
Lower than Peers by 6.64
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
-1.87
|
2.40
|
-0.74
|
-1.91
|
-2.93
|
|
Peer Median
|
4.77
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
24.67
Higher than Peers by 3.40
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
24.67
|
11.33
|
14.80
|
18.20
|
14.25
|
|
Peer Median
|
21.27
|
--
|
--
|
--
|
--
|
Asset Turnover
0.55
Higher than Peers by 0.15
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
0.55
|
0.55
|
0.65
|
0.42
|
0.36
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
--
|
58.68
|
60.46
|
60.95
|
71.60
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
--
|
304.96
|
175.08
|
180.06
|
196.99
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
--
|
54.23
|
47.31
|
57.15
|
65.85
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
--
|
309.41
|
188.23
|
183.86
|
202.73
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
--
|
12.31
|
-2.72
|
-0.16
|
-2.79
|
|
Peer Median
|
37.31
|
--
|
--
|
--
|
--
|
Price / Book Value
0.73
Lower than Peers by 7.02
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
0.73
|
1.24
|
1.07
|
0.19
|
0.42
|
|
Peer Median
|
7.75
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
EV/EBITDA
5.24
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
5.24
|
4.22
|
20.50
|
-18.39
|
87.46
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
247
Lower than Peers by 2,344
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Emergent Biosolutions Inc (EBS)
|
247
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2,591
|
--
|
--
|
--
|
--
|